Beranda › Limfoma Folikuler
Uji klinis Limfoma Folikuler yang merekrut di AS
107 studi untuk Limfoma Folikuler merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- New York City, NY24 studi
- Milwaukee, WI19 studi
- Houston, TX18 studi
- Nashville, TN18 studi
- Boston, MA17 studi
- Baldwin Park, CA16 studi
- Seattle, WA15 studi
- Durham, NC15 studi
- Columbus, OH13 studi
- Salt Lake City, UT13 studi
- Philadelphia, PA12 studi
- San Antonio, TX12 studi
- Chicago, IL12 studi
- Dallas, TX11 studi
- Denver, CO11 studi
- Los Angeles, CA11 studi
- Edison, NJ11 studi
- Washington, DC11 studi
- Atlanta, GA11 studi
- Rochester, MN10 studi
- Jacksonville, FL10 studi
- Portland, OR9 studi
- Cincinnati, OH9 studi
- Cleveland, OH9 studi
- New Haven, CT9 studi
- Pittsburgh, PA8 studi
- San Francisco, CA8 studi
- Miami, FL8 studi
- San Diego, CA8 studi
- Charlotte, NC7 studi
- Tampa, FL7 studi
- Clifton, NJ7 studi
- St. Louis, MO7 studi
- Mountain View, CA7 studi
- Queens, NY7 studi
- Cedar Rapids, IA7 studi
- Austin, TX6 studi
- Greenburgh, NY6 studi
- Winston-Salem, NC6 studi
- Buffalo, NY5 studi
Berdasarkan negara bagian
- Alabama5 studi
- Arizona11 studi
- Arkansas3 studi
- California36 studi
- Colorado14 studi
- Connecticut10 studi
- Delaware4 studi
- Distrik Columbia4 studi
- Florida25 studi
- Georgia15 studi
- Illinois14 studi
- Indiana7 studi
- Iowa9 studi
- Kansas7 studi
- Kentucky10 studi
- Louisiana8 studi
- Maryland9 studi
- Massachusetts20 studi
- Michigan12 studi
- Minnesota18 studi
- Mississippi4 studi
- Missouri9 studi
- Nebraska4 studi
- New Jersey15 studi
- New Mexico3 studi
- New York30 studi
- North Carolina23 studi
- Ohio23 studi
- Oklahoma4 studi
- Oregon11 studi
- Pennsylvania17 studi
- Rhode Island4 studi
- South Carolina6 studi
- Tennessee19 studi
- Texas35 studi
- Utah13 studi
- Virginia9 studi
- Washington19 studi
- Wisconsin21 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT03460977Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
Menerima pesertaFase 3
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07215910Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Menerima pesertaStudi observasional
Usia 0 hingga 38 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT061318015HTP Regulation Of Asthma In Children
Menerima pesertaFase 2
Usia 8 hingga 18 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT04160910Buprenorphine Implementation at Syringe Service Programs to Reduce Overdoses
Menerima pesertaSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07631598A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT06542250A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT05006716Rituximab and Zanubrutinib in Patients With Indolent B-cell Lymphomas
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT06350318A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)
Menerima pesertaFase 2/3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07634471A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07519772Epco, Zanu, Ritux for R/R FL or MZL
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06563596Vaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T Treatment
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT06784167A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07226843Mosunetuzumab and Polatuzumab Vedotin for the Treatment of Patients With Relapsed or Refractory Grade 1-3a Follicular Lymphoma
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06453044A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07101328A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT05765812A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
Menerima pesertaFase 3
Usia 18 hingga 130 · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT06549595huCART19-IL18-eDHFR Cells in Relapsed/Refractory Follicular Lymphoma
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07343934NEO100 and High-Grade Meningioma
Menerima pesertaFase 2
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT05023018Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT06526793Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
Menerima pesertaFase 3
Usia 12 hingga 100 · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT06784752A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT06091254Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT07225439A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular Lymphoma
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT06043323A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
Menerima pesertaStudi observasional
Usia 0 ke atas · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT07154823Dari ClinicalTrials.gov, data diambil 3 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.